From post

Evaluating the risks and benefits of Phase II and III cancer clinical trials: A look at Institutional Review Boards in the Netherlands

, , , и . IRB: Ethics and Human Research, 29 (1): 13-18 (января 2007)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем